Marshall Wace North America Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$263M |
| 2 |
NextEra Energy
NEE
|
+$129M |
| 3 |
Coca-Cola
KO
|
+$123M |
| 4 |
NVIDIA
NVDA
|
+$121M |
| 5 |
Johnson & Johnson
JNJ
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$357M |
| 2 |
Humana
HUM
|
+$214M |
| 3 |
HCA Healthcare
HCA
|
+$189M |
| 4 |
Alibaba
BABA
|
+$169M |
| 5 |
GoDaddy
GDDY
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.58% |
| 2 | Technology | 21.08% |
| 3 | Consumer Discretionary | 11.47% |
| 4 | Industrials | 8.77% |
| 5 | Financials | 7.84% |
Similar funds
Marshall Wace North America's Q1 2020 Portfolio in Review
As of Q1 2020, Marshall Wace North America held 1,781 positions worth $13.2B, down 36% from $20.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace North America withdrew a net $3.85B in Q1 2020, closing 600 positions and reducing 364 holdings. Its most notable exit was Everpure Inc, an estimated $87.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in UnitedHealth worth $238M.
- Marshall Wace North America's largest Q1 2020 buy was UnitedHealth: 954,482 shares worth $238M.
- Marshall Wace North America added most to Coca-Cola in Q1 2020, an estimated $123M increase.
- Marshall Wace North America's biggest Q1 2020 reduction was Boeing, cutting an estimated $357M.
- Marshall Wace North America fully exited Everpure Inc in Q1 2020, selling an estimated $87.4M.
- Marshall Wace North America's ten largest holdings make up 19% of its $13.2B portfolio in Q1 2020.
- Marshall Wace North America opened 526 new positions and closed 600 in Q1 2020.
- Marshall Wace North America's portfolio value fell 36% quarter-over-quarter to $13.2B.
Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.